DE69923829D1 - Zusammensetzung von nucleinsäuren und acemannan - Google Patents
Zusammensetzung von nucleinsäuren und acemannanInfo
- Publication number
- DE69923829D1 DE69923829D1 DE69923829T DE69923829T DE69923829D1 DE 69923829 D1 DE69923829 D1 DE 69923829D1 DE 69923829 T DE69923829 T DE 69923829T DE 69923829 T DE69923829 T DE 69923829T DE 69923829 D1 DE69923829 D1 DE 69923829D1
- Authority
- DE
- Germany
- Prior art keywords
- acemannan
- composition
- nucleic acids
- nucleic
- acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- XOYXESIZZFUVRD-UVSAJTFZSA-M acemannan Chemical compound CC(=O)O[C@@H]1[C@H](O)[C@@H](OC)O[C@H](CO)[C@H]1O[C@@H]1[C@@H](O)[C@@H](OC(C)=O)[C@H](O[C@@H]2[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O[C@@H]4[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]5[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]6[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]7[C@H]([C@@H](OC(C)=O)[C@H](OC)[C@@H](CO)O7)O)[C@@H](CO)O6)O)[C@H](O5)C([O-])=O)O)[C@@H](CO)O4)O)[C@@H](CO)O3)NC(C)=O)[C@@H](CO)O2)O)[C@@H](CO)O1 XOYXESIZZFUVRD-UVSAJTFZSA-M 0.000 title 1
- 229960005327 acemannan Drugs 0.000 title 1
- 150000007523 nucleic acids Chemical group 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU1998126A CU22740A1 (es) | 1998-09-07 | 1998-09-07 | Formulación de ácidos nucleicos y acemanano |
| PCT/CU1999/000004 WO2000013704A1 (es) | 1998-09-07 | 1999-09-03 | Formulacion de acidos nucleicos y acemanano |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE69923829D1 true DE69923829D1 (de) | 2005-03-31 |
Family
ID=5459419
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69923829T Expired - Lifetime DE69923829D1 (de) | 1998-09-07 | 1999-09-03 | Zusammensetzung von nucleinsäuren und acemannan |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6358933B1 (de) |
| EP (1) | EP1029549B1 (de) |
| CN (1) | CN1287493A (de) |
| AR (1) | AR020403A1 (de) |
| AT (1) | ATE289518T1 (de) |
| BR (1) | BR9906761A (de) |
| CA (1) | CA2308444A1 (de) |
| CU (1) | CU22740A1 (de) |
| DE (1) | DE69923829D1 (de) |
| WO (1) | WO2000013704A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7223739B1 (en) | 1995-06-07 | 2007-05-29 | Powderject Vaccines, Inc. | Adjuvanted genetic vaccines |
| US7022320B1 (en) | 1999-02-09 | 2006-04-04 | Powderject Vaccines, Inc. | Mycobacterium tuberculosis immunization |
| ES2340617T3 (es) * | 1999-11-03 | 2010-06-07 | Powderject Vaccines, Inc. | Vacunas geneticas con adyuvantes. |
| US9200036B2 (en) | 2002-07-12 | 2015-12-01 | The Johns Hopkins University | Mesothelin vaccines and model systems |
| US20090110702A1 (en) | 2002-07-12 | 2009-04-30 | The Johns Hopkins University | Mesothelin Vaccines and Model Systems and Control of Tumors |
| WO2004006837A2 (en) * | 2002-07-12 | 2004-01-22 | The Johns Hopkins University | Mesothelin vaccines and model systems |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5106616A (en) * | 1988-01-14 | 1992-04-21 | Carrington Laboratories, Inc. | Administration of acemannan |
| IL104382A0 (en) * | 1992-01-17 | 1993-05-13 | Solvay Animal Health Inc | Vaccine containing acemannan as an adjuvant |
-
1998
- 1998-09-07 CU CU1998126A patent/CU22740A1/es unknown
-
1999
- 1999-09-03 AT AT99942707T patent/ATE289518T1/de not_active IP Right Cessation
- 1999-09-03 US US09/530,925 patent/US6358933B1/en not_active Expired - Fee Related
- 1999-09-03 EP EP99942707A patent/EP1029549B1/de not_active Expired - Lifetime
- 1999-09-03 DE DE69923829T patent/DE69923829D1/de not_active Expired - Lifetime
- 1999-09-03 WO PCT/CU1999/000004 patent/WO2000013704A1/es active IP Right Grant
- 1999-09-03 BR BR9906761-7A patent/BR9906761A/pt not_active IP Right Cessation
- 1999-09-03 CA CA002308444A patent/CA2308444A1/en not_active Abandoned
- 1999-09-03 CN CN99801915A patent/CN1287493A/zh active Pending
- 1999-09-07 AR ARP990104496A patent/AR020403A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2308444A1 (en) | 2000-03-16 |
| CN1287493A (zh) | 2001-03-14 |
| WO2000013704A1 (es) | 2000-03-16 |
| EP1029549B1 (de) | 2005-02-23 |
| ATE289518T1 (de) | 2005-03-15 |
| AR020403A1 (es) | 2002-05-08 |
| US6358933B1 (en) | 2002-03-19 |
| EP1029549A1 (de) | 2000-08-23 |
| BR9906761A (pt) | 2000-10-03 |
| CU22740A1 (es) | 2002-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69928195D1 (de) | Komplettierung von Untrerdruck-Bohrlöchern | |
| DE69831755D1 (de) | Optoakustische kontrastmittel und anwendungsverfahren | |
| DE69814069D1 (de) | Neuartige form von s-omeprazol | |
| DE69835020D1 (de) | Plasmabrenner und verwendungsverfahren dieses plasmabrenners | |
| DE69431719T2 (de) | Hybridisierung und sequenzierung von nukleinsäuren | |
| ATE351910T1 (de) | Ob-fusionsprotein enthaltende zusammensetzungen und verfahren | |
| MA26668A1 (fr) | ACTIVATEURS DE hPPARy ET hPPARa | |
| DE69732881D1 (de) | Verwendung von zusammensetzungen mit stabilisierten enzymen | |
| EP0981511A4 (de) | Methoden und zusammensetzungen zur selektiven modifikation von nukleinsäuren | |
| DE69832490D1 (de) | Vervielfältigung von nukleinsäuren | |
| ID28728A (id) | Komposisi dan proses pengkrepan | |
| DE69930647D1 (de) | Struktur-analoga von amin-basen und nucleosiden | |
| EP1019083A4 (de) | Verfahren und zusammensetzungen zur selektiven modifizierung von nukleinsäuren | |
| ID24196A (id) | Komposisi dan penggunaan | |
| DE69838832D1 (de) | Zusammensetzung von vermischbaren Pigmenten | |
| DE69805853D1 (de) | Modifizierte lithium-vanadium-oxidelektrodenmaterialien, produkte und verfahren | |
| FI980246A0 (fi) | Menetelmä keittimen käyttämiseksi ja keitin | |
| DE69921311D1 (de) | Vervielfältigung von nukleinsäuren | |
| DE69907146T2 (de) | Direkte oxidation von cycloalkanen | |
| DE59708905D1 (de) | Injektionsformulierungen von avermectinen und milbemycinen | |
| DE69915591D1 (de) | Zusammensetzungen von 1,1,1,3,3-pentafluorpropan und trans-1,2-dichlorethylen | |
| DE69816046D1 (de) | Zusammensetzung auf basis von hexanitrohexaazaisowurtizitan und hexanitrohexaazaisowurtizitan enthaltende sprengstoffzusammensetzung | |
| DE69813488D1 (de) | Härtbare Zusammensetzungen und gehärtete Gel-Gegenstände daraus | |
| DK0713648T3 (da) | Hidtil ukendt sammensætning af hævesyrer | |
| DE69923829D1 (de) | Zusammensetzung von nucleinsäuren und acemannan |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8332 | No legal effect for de |